Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

MAN 01 companion diagnostic - Q BioMed/Washington University in St. Louis

Next Previous
Drug Profile

MAN 01 companion diagnostic - Q BioMed/Washington University in St. Louis

Alternative Names: GDF 15 companion diagnostic - Q Biomed/Washington University in St. Louis; GDF-15 - Q BioMed; GDF15 - Q BioMed/Washington University in St. Louis; MAN 11 companion diagnostic - Q Biomed/Washington University in St. Louis

Latest Information Update: 28 Jan 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Washington University
  • Developer Q BioMed; Washington University
  • Class Diagnostic agents
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Glaucoma

Most Recent Events

  • 28 Jan 2024 No recent reports of development identified for clinical-Phase-Unknown development in Glaucoma(Diagnosis) in USA
  • 27 Sep 2022 Q BioMed has patent protection for MAN 01 companion diagnostic in Europe
  • 31 Dec 2020 Clinical trials in Glaucoma (Diagnosis) in USA (unspecified route) before December 2020

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top